Open original FDA record ↗Recall record
- FDA identifier
- Z-0446-2019
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA record creation date
- Nov 10, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Firm identified an issue in the manufacturing process which might contribute to elevated rates of false positive results for HSV-1 while using the ME Panel. Only specific kits are affected.
Source facts
- Action
- On 09/10/2018, the firm sent an Urgent Medical Device Recall Letter via FedEx to the Recall Coordinator/Laboratory Director for all consignees. Consignees are instructed to: -Immediately examine their inventory for products with the affected Lot numbers and to discontinue use and to discard any remaining product in their possession that is subject to the recall.. BioFire will replace discarded product at no charge. -If the consignee has further distributed the affected product, they are to identify these customers and to notify them at once of the product recall. -Complete and return the Acknowledgement of Receipt Form that was enclosed with the Customer Advisory Notice letter, as soon as possible, and to return the Acknowledgement Form to the firm. Consignees were provided with firm contact information including phone numbers: 801-736-6354 and 1-800-735-6544
- Initiated
- 2018-09-10
- Root cause
- Material/Component Contamination
- Terminated
- 2021-04-28
- Distribution
- Worldwide Distribution - US Nationwide in the states of: CA DC, FL, IN, KY, MN, MO, NB, NJ, OH, TX and WI. International: Canada, Columbia and Mexico
- Recall number
- Z-0446-2019
- Recall status
- Terminated
- CDRH record ID
- 167757
- FDA record created
- 2018-11-10
- Recall event number
- 81197